Age: 62.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chills, Headache, Pyrexia
Clinical narrative: Chills; Headaches; A little bit of a fever; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 63-year-old female patient received BNT162b2 (BNT162B2), in Nov2021 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 62 years for covid-19 immunisation. The patient's relevant medical history included: "Diabetes" (unspecified if ongoing); "Asthma" (unspecified if ongoing); "Hypertension" (unspecified if ongoing); "Covid-19" (unspecified if ongoing), notes: Before caller got her very first primary shot of the Pfizer Covid 19 vaccine, caller had Covid, which was two weeks before caller got the first shot. The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose: 01), for Covid-19 immunization; Bnt162b2 (Dose: 02), for Covid-19 immunization. The following information was reported: CHILLS (non-serious), outcome "unknown"; HEADACHE (non-serious), outcome "unknown", described as "Headaches"; PYREXIA (non-serious), outcome "unknown", described as "A little bit of a fever".  Additional information included: Consumer on the other line calling about the Pfizer COVID-19 vaccine. Caller was currently 63 years of age and took the first booster shot for the vaccine last Nov2021. Caller was 62-year-old when caller got her first booster shot. Caller was calling to inquire if she would be eligible to get the second booster shot, caller had not taken the second booster shot yet. Caller mentioned she had a few pre-existing medical conditions such as diabetes, asthma, and hypertension. Also mentioned that before caller got her very first primary shot of the Pfizer Covid 19 vaccine, caller had Covid, which was two weeks before caller got the first shot. Caller also mentioned that she experienced headaches and felt like she had Covid again, transfer agent not able to specify if this occurred with the first, second, or third shot. Caller also mentioned that she ended up in the hospital for 6 days and this caused her to be off work for 2 months. Caller also mentioned that her sister who also got the Pfizer COVID-19 shot did not experience the same side effects as caller's side effects. Transfer agent believes that caller's sister did not experience any side effects, but transfer agent is not sure. This was the transfer agents second attempt to transfer the caller to Pfizer Drug Safety, the first agent transfer agent spoke with transfer agent did not get a report reference or NTID. Transfer agent was not sure if filed a report already for this information. Caller confirms event details upon transfer. Caller was getting in the car, just got off of work. Give caller a few minutes to put stuff in her car. When caller took the booster caller had a headache, caller states she had a coworker calling her right now. All caller was wanting to know was if she could take the second booster because caller was due for the second booster in May. Transfer agent told caller she could take the second booster 4 months after the first booster. Each time caller took the booster, caller had a headache, chills, and a little bit of a fever, lasted a day or so and was told that was normal. Declined to confirm reporter details or complete a report because caller's coworker was calling her and she was not sure why her coworker was calling her. Unable to clarify event details with caller or clarify which dose of the Pfizer COVID-19 vaccine caller experienced her side effects.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.